KIMBERLY GIBSON: Open Payments
NPI 1699322024 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 11 payments from 4 companies in 2025. Trend: 2023 $240 · 2024 $151 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $314 |
| ABBVIE INC. | 3 | $50 |
| Lilly USA, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, VRAYLAR, MOUNJARO, CAPLYTA.
Industry payments across MS — which companies pay providers there.
